Jonathan Caulkins
Jonathan Caulkins
Verified email at
Cited by
Cited by
Drug policy and the public good
TF Babor, JP Caulkins, G Edwards, B Fischer, DR Foxcroft, K Humphreys, ...
Oxford university press, 2010
Optimal control of nonlinear processes
D Grass, JP Caulkins, G Feichtinger, G Tragler, DA Behrens
Berlino: Springer, 2008
Marijuana legalization: What everyone needs to know®
JP Caulkins, B Kilmer, MAR Kleiman
Oxford University Press, 2016
What price data tell us about drug markets
JP Caulkins, P Reuter
Journal of drug issues 28 (3), 593-612, 1998
Drug policy and the public good: evidence for effective interventions
J Strang, T Babor, J Caulkins, B Fischer, D Foxcroft, K Humphreys
The Lancet 379 (9810), 71-83, 2012
Variation in cannabis potency and prices in a newly legal market: evidence from 30 million cannabis sales in Washington state
R Smart, JP Caulkins, B Kilmer, S Davenport, G Midgette
Addiction 112 (12), 2167-2177, 2017
Developing public health regulations for marijuana: lessons from alcohol and tobacco
RL Pacula, B Kilmer, AC Wagenaar, FJ Chaloupka, JP Caulkins
American journal of public health 104 (6), 1021-1028, 2014
Mandatory minimum drug sentences: Throwing away the key or the taxpayers' money?
JP Caulkins, CP Rydell, WL Schwabe, J Chiesa
Considering marijuana legalization: Insights for Vermont and other jurisdictions
JP Caulkins, B Kilmer, M Kleiman, RJ MacCoun, G Midgette, P Oglesby, ...
Rand Corporation, 2015
Public health implications of legalising the production and sale of cannabis for medicinal and recreational use
W Hall, D Stjepanović, J Caulkins, M Lynskey, J Leung, G Campbell, ...
The Lancet 394 (10208), 1580-1590, 2019
How drug enforcement affects drug prices
JP Caulkins, P Reuter
Crime and Justice 39 (1), 213-271, 2010
Altered state?: assessing how marijuana legalization in California could influence marijuana consumption and public budgets
B Kilmer, JP Caulkins, RL Pacula, RJ MacCoun, P Reuter
RAND, 2010
Marijuana markets: Inferences from reports by the household population
JP Caulkins, RL Pacula
Journal of Drug Issues 36 (1), 173-200, 2006
Three strikes and you’re out: Estimated benefits and costs of California’s new mandatory-sentencing law
PW Greenwood, CP Rydell, AF Abrahamse, JP Caulkins, J Chiesa, ...
Santa Monica, CA: Rand, 1994
Enforcement or treatment? Modeling the relative efficacy of alternatives for controlling cocaine
CP Rydell, JP Caulkins, SS Everingham
Operations Research 44 (5), 687-695, 1996
Research note—Sell first, fix later: Impact of patching on software quality
A Arora, JP Caulkins, R Telang
Management Science 52 (3), 465-471, 2006
An Ounce of Prevention, a Pound of Uncertainty: The Cost-Effectiveness of School-Based Drug Prevention Programs.
JP Caulkins, CP Rydell, SS Everingham, J Chiesa, S Bushway
RAND, 1700 Main St., PO Box 2138, Santa Monica, CA 90407-2138; 1333 H St …, 1999
A dynamic model of drug initiation: implications for treatment and drug control
DA Behrens, JP Caulkins, G Tragler, JL Haunschmied, G Feichtinger
Mathematical Biosciences 159 (1), 1-20, 1999
Drugs and Drug Policy: What Everyone Needs to Know®
MAR Kleiman, JP Caulkins, A Hawken
Oxford University Press, 2011
Price and purity analysis for illicit drug: Data and conceptual issues
JP Caulkins
Drug and Alcohol Dependence 90, S61-S68, 2007
The system can't perform the operation now. Try again later.
Articles 1–20